Grantham, Mayo, Van Otterloo & Co (GMO)
SPPI

Grantham, Mayo, Van Otterloo & Co (GMO)’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio SPPI Stock Details SPPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-21,600
Closed -$409K – 641
2017
Q4 		$409K Buy
21,600
+6,300
+41% +$114K ﹤0.01% 477
2017
Q3 		$215K Buy
+15,300
New +$138K ﹤0.01% 531

Other funds holding SPPI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s SPPI Position: Q1 2018 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q1 2018, closing a stake of 21,600 shares — an estimated $409K sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in SPPI in Q3 2017 and held it in 2 quarters. The position peaked at $409K in Q4 2017. 161 funds tracked by Wall St. Rank hold SPPI as of Q1 2018.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Spectrum Pharmaceuticals Inc position as of Q1 2018 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 21,600 Spectrum Pharmaceuticals Inc shares in Q1 2018, an estimated $409K.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Spectrum Pharmaceuticals Inc in Q3 2017 and held it in 2 quarters.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Spectrum Pharmaceuticals Inc position peaked at $409K in Q4 2017.
  • 161 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q1 2018.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q1 2018, filed 15 May 2018.